# 18F-FLT (PET/CT) in Pediatrics With Myeloproliferative Neoplasms

> **NCT03121599** · NA · TERMINATED · sponsor: **Hamad Medical Corporation** · enrollment: 3 (actual)

## Conditions studied

- Essential Thrombocythemia
- Primary Myelofibrosis, Fibrotic Stage
- Primary Myelofibrosis, Prefibrotic Stage
- Polycythemia Vera

## Interventions

- **DEVICE:** Diagnostic (18F-FLT PET/CT)

## Key facts

- **NCT ID:** NCT03121599
- **Lead sponsor:** Hamad Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-06-11
- **Primary completion:** 2018-10-15
- **Final completion:** 2018-10-16
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Delayed study materials, poor recruitment
- **Last updated:** 2020-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03121599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03121599, "18F-FLT (PET/CT) in Pediatrics With Myeloproliferative Neoplasms". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03121599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*